Analysis

• Health & Medicine

Cancer waiting times: Latest updates and analysis

Get the latest updates and analysis on NHS cancer waiting times in England, and learn what it means for people affected by cancer Get the latest updates and analysis on NHS cancer waiting times in England, and learn what it means for people affected by cancer

12 June 2025

• Policy & Insight

Spending Review 2025: What does it mean for cancer?

We analyse the Spending Review, the financial foundation for the next several years of cancer research and care We analyse the Spending Review, the financial foundation for the next several years of cancer research and care

11 June 2025

• Health & Medicine

Another screening success story: England changes cervical screening to every 5 years

We explain NHS England's move to invite people for cervical screening every five years instead of every three years. We explain NHS England's move to invite people for cervical screening every five years instead of every three years.

10 June 2025

• Science & Technology

Liquid biopsy tests could help treat children and young people with cancer

A new blood test that uncovers hidden changes inside cancer cells could help doctors find the best treatments for children and young people with cancer. A new blood test that uncovers hidden changes inside cancer cells could help doctors find the best treatments for children and young people with cancer.

9 June 2025

• Policy & Insight

Seizing the moment – 5 steps the Government must take to help UK cancer research thrive

Building on insights from our research community, we’re outlining five steps the Government must take to strengthen cancer research, and the wider ecosystem it sits within, so it can continue delivering life-saving tests and treatments.  Building on insights from our research community, we’re outlining five steps the Government must take to strengthen cancer research, and the wider ecosystem it sits within, so it can continue delivering life-saving tests and treatments. 

5 June 2025

• For Researchers

Big data and cancer – our greatest obstacles present a real opportunity

The potential of big data must be realised in the right way. To do this, says Gemma Codner, we must overcome many challenges… The potential of big data must be realised in the right way. To do this, says Gemma Codner, we must overcome many challenges…

23 April 2025

• Policy & Insight

Less red tape and lower costs: How the UK-EU political reset can support cancer research progress worldwide

As we launch our new report, “Nothing should stand in the way”, we reflect on how the UK and EU could be more ambitious, grasping opportunities for closer scientific cooperation to promote health and wealth across the continent and beyond As we launch our new report, “Nothing should stand in the way”, we reflect on how the UK and EU could be more ambitious, grasping opportunities for closer scientific cooperation to promote health and wealth across the continent and beyond

22 April 2025

• Policy & Insight

A key milestone passed: The Tobacco and Vapes Bill completes Report Stage and Third Reading Stage in the House of Commons

After hours of debate in the House of Commons, MPs have voted in favour of the Tobacco and Vapes Bill during its Third Reading. After hours of debate in the House of Commons, MPs have voted in favour of the Tobacco and Vapes Bill during its Third Reading.

27 March 2025

• Health & Medicine

Welsh Senedd Members vote to pass food promotion legislation

Today, Senedd Members voted to bring in new laws to help make it easier to choose healthier food and drink options in Wales. Today, Senedd Members voted to bring in new laws to help make it easier to choose healthier food and drink options in Wales.

25 March 2025

• Policy & Insight

Early warnings, better outcomes: Getting the infrastructure right to unlock data for cancer detection

To get the most out of data-driven programmes we need to see some changes in the UK’s health data infrastructure. Here we explore what those changes need to be, and how programmes like CD3 can align with government’s priorities.  To get the most out of data-driven programmes we need to see some changes in the UK’s health data infrastructure. Here we explore what those changes need to be, and how programmes like CD3 can align with government’s priorities. 

19 March 2025

• Policy & Insight

Research clusters: How the Industrial Strategy can enhance the UK life sciences ecosystems

Today we've published a new report outlining our expertise in building research clusters and how they can boost the UK R&D landscape Today we've published a new report outlining our expertise in building research clusters and how they can boost the UK R&D landscape

12 March 2025